BOK and colorectal cancer: On the other hand, studies also report that stage II and III colorectal cancer (malignant complication observed in CD) patients show a decreased level of BOK protein in their tumors compared to the normal tissues, and increased levels are associated with earlier colorectal cancer recurrence and reduced overall survival.